Breast cancer screening: a different look at the evidence.

摘要: The data on screening for breast cancer were studied to extract information rates of biopsy recommendation, detection benign disease, and mortality. Relative absolute mortality other causes calculated. Approximately 5% women screened have a suspicious result are referred further assessment. reduction in attributed procedures ranges from 0.049% 0.144% the population, demonstrating that up 2041 must be each woman who will benefit. If subjected operation disease considered harmed by program, then harm/benefit ratio 62:1. It is suggested enough question cost/harm/benefit already available make decision mass should abandoned procedure reserved those with high-risk factors.